2018-2023 Global Gastrointestinal Consumption Market Report - MarketResearchNest.com

2018-2023 Global Gastrointestinal Consumption Market Report

Description :
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Gastrointestinal market for 2018-2023.

Gastrointestinal (GI) ...

Publish Date : 12-Jul-2018

No.Of Pages : 164

Offer : Enquire Now

Categories :

Published by :

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Gastrointestinal market for 2018-2023.

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
The global average gross margin of Gastrointestinal is in a slight decreasing trend, and the gross margin is 63% in 2015.
Europe region is the largest supplier of Gastrointestinal, with a production revenue market share nearly 50% in 2015. North America is the second largest supplier of Gastrointestinal, enjoying production revenue market share nearly 22% in 2015.
North America is the largest consumption place, with a consumption value market share nearly 52% in 2015. Following North America, Europe is the second largest consumption place with the consumption value market share of 22% in 2015.
Market competition is intense. AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. are the leaders of the industry, and they hold high-end customers, and their products are famous in the world.
With the development of economic, more and more companies participate in this industry with their new type products.
Over the next five years, LPI(LP Information) projects that Gastrointestinal will register a 0.9% CAGR in terms of revenue, reach US$ 35300 million by 2023, from US$ 33600 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Segmentation by application:
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East and Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
AstraZenec
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria(Tillotts)
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Gastrointestinal consumption (value and volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Gastrointestinal market by identifying its various subsegments.
Focuses on the key global Gastrointestinal manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Gastrointestinal with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Gastrointestinal submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

SECONDARY RESEARCH

Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH

Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING

The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION

The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION

After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Single User License - Only one user can access this report at time, users are not allowed to take a print out of the report PDF.

Enterprise User License - This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish to receive the hard copy version of this report.

Multi User License - This license will be allowing up to five users have access to the product. The report will be emailed to you. The report is sent in PDF format.

Site License - This is a site license, allowing all users within a given geographical location of your organisation access to the product. The report will be emailed to you. The report is sent in PDF format.

Purchase Option


 Single User PDF     $ 4660
 Multi-User PDF      $ 6990
 Enterprise PDF      $ 9320

NEED Help?

If you need any help or guidance, please feel free to call us.

USA: +1 (240) 284 8070 UK : +44 20 3290 4151

or

Write us on :

info@marketresearchnest.com